• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Outcomes of a Peri- and Postoperative Management Protocol for Non-TB Mycobacteria in Lung Transplant Recipients.

作者信息

Hirama Takashi, Singer Lianne G, Brode Sarah K, Marras Theodore K, Husain Shahid

机构信息

Department of Medicine, University of Toronto, Toronto, ON, Canada; Multi-Organ Transplant Program, Divisions of Respirology, Toronto General Hospital, Toronto, ON, Canada; Nontuberculous Mycobacteria Program, Division of Respirology, Toronto Western Hospital, Toronto, ON, Canada; West Park Healthcare Centre, Toronto, ON, Canada; Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Miyagi, Japan.

Department of Medicine, University of Toronto, Toronto, ON, Canada; Multi-Organ Transplant Program, Divisions of Respirology, Toronto General Hospital, Toronto, ON, Canada.

出版信息

Chest. 2020 Aug;158(2):523-528. doi: 10.1016/j.chest.2020.01.056. Epub 2020 Apr 2.

DOI:10.1016/j.chest.2020.01.056
PMID:32247715
Abstract
摘要

相似文献

1
Outcomes of a Peri- and Postoperative Management Protocol for Non-TB Mycobacteria in Lung Transplant Recipients.肺移植受者非结核分枝杆菌围手术期及术后管理方案的结果
Chest. 2020 Aug;158(2):523-528. doi: 10.1016/j.chest.2020.01.056. Epub 2020 Apr 2.
2
Early onset of nontuberculous mycobacterial pulmonary disease contributes to the lethal outcome in lung transplant recipients: report of two cases and review of the literature.非结核分枝杆菌肺病的早期发病导致肺移植受者的致命结局：两例报告及文献综述
Transpl Infect Dis. 2016 Feb;18(1):112-9. doi: 10.1111/tid.12481. Epub 2016 Jan 30.
3
Granulomatous fungal and non-tuberculous mycobacterial infestation complicating chronic lung disease: Outcomes in patients undergoing lung transplantation.慢性肺部疾病合并肉芽肿性真菌感染和非结核分枝杆菌感染：肺移植患者的结局。
Ann Diagn Pathol. 2021 Dec;55:151832. doi: 10.1016/j.anndiagpath.2021.151832. Epub 2021 Sep 30.
4
Management of De Novo Mycobacterial Infection After Lung Transplantation Without Rifampicin: Case Series of a Single Institution.肺移植后无利福平的新发分枝杆菌感染的管理：单机构病例系列
Transplant Proc. 2018 Nov;50(9):2764-2767. doi: 10.1016/j.transproceed.2018.03.058. Epub 2018 Mar 15.
5
Atypical mycobacteriosis in a lung transplant recipient.一名肺移植受者的非典型分枝杆菌病
Eur Respir J. 1997 Apr;10(4):952-4.
6
Nontuberculous mycobacterial and Aspergillus infections among cadaveric lung transplant recipients in Japan.日本尸体肺移植受者中的非结核分枝杆菌和曲霉感染。
Respir Investig. 2018 May;56(3):243-248. doi: 10.1016/j.resinv.2017.12.010. Epub 2018 Feb 4.
7
Non-tuberculous mycobacterial infection among lung transplant recipients: a 15-year cohort study.肺移植受者中的非结核分枝杆菌感染：一项15年队列研究。
Transpl Infect Dis. 2012 Oct;14(5):452-60. doi: 10.1111/j.1399-3062.2012.00753.x. Epub 2012 Jun 8.
8
Non-tuberculous mycobacteria in lung transplant recipients: Prevalence, risk factors, and impact on survival and chronic lung allograft dysfunction.肺移植受者中的非结核分枝杆菌：患病率、危险因素及其对生存和慢性肺移植功能障碍的影响。
Transpl Infect Dis. 2020 Apr;22(2):e13229. doi: 10.1111/tid.13229. Epub 2019 Dec 16.
9
Analysis of pulmonary non-tuberculous mycobacterial infections after lung transplantation.肺移植术后肺部非结核分枝杆菌感染的分析
Transpl Infect Dis. 2016 Aug;18(4):585-91. doi: 10.1111/tid.12546. Epub 2016 Jul 2.
10
Mycobacterium abscessus Complex - a Particular Challenge in the Setting of Lung Transplantation.脓肿分枝杆菌复合体 - 肺移植中的特殊挑战。
Expert Rev Anti Infect Ther. 2016;14(3):325-33. doi: 10.1586/14787210.2016.1138856. Epub 2016 Feb 3.

引用本文的文献

1
Nontuberculous mycobacterial disease in children: A systematic review and meta-analysis.儿童非结核分枝杆菌病：一项系统评价和荟萃分析。
Heliyon. 2024 May 22;10(11):e31757. doi: 10.1016/j.heliyon.2024.e31757. eCollection 2024 Jun 15.
2
Non-tuberculous mycobacterial disease: progress and advances in the development of novel candidate and repurposed drugs.非结核分枝杆菌病：新型候选药物和再利用药物研发的进展与突破。
Front Cell Infect Microbiol. 2023 Oct 2;13:1243457. doi: 10.3389/fcimb.2023.1243457. eCollection 2023.
3
Outcome and prognostic factors after lung transplantation for bronchiectasis other than cystic fibrosis.
支气管扩张症（非囊性纤维化）肺移植术后的结果和预后因素。
BMC Pulm Med. 2021 Aug 13;21(1):261. doi: 10.1186/s12890-021-01634-z.